Cytokinetics | CYTK - Capital Ordinário





Capital Ordinário Alterar Data
Acadia Pharmaceuticals USD 169.18M 470K 2025-12
Amgen USD 539M 1000K 2025-12
Arca Biopharma USD 37K 0 2025-03
Bayer EUR 982.42M 0 2025-12
Biogen USD 146.7M 200K 2025-09
Brainstorm Cell Therapeutics USD 15K 1000 2025-03
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Capricor Therapeutics USD 46K 0 2025-03
Cytokinetics USD 122.26M 145K 2025-12
Eisai JPY 282.11M 1000 2025-12
Eli Lilly USD 946.83M 354.23M 2025-06
Exelixis USD 268.1M 2.03M 2025-09
Geron USD 638.36M 338K 2025-12
Halozyme Therapeutics USD 117.78M 259K 2025-12
Ionis Pharmaceuticals USD 161.97M 836K 2025-12
Ligand Pharmaceuticals USD 19.66M 19.64M 2025-09
Merck USD 2.49B 15.79M 2025-09
Novartis USD 1.94B 23.4M 2025-06
Pfizer USD 5.69B 1000K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12